As of Apr 24
| -0.14 / -2.37%|
The 4 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 7.50, with a high estimate of 11.00 and a low estimate of 6.50. The median estimate represents a +30.21% increase from the last price of 5.76.
The current consensus among 5 polled investment analysts is to Hold stock in Pacific Biosciences of California Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.